GGrantIndex
Sort

11,323 grants matching glioblastoma

Exploiting cell fate transition to overcome radiation resistance in glioblastoma

$709,593
Erik Sulman · New York University School Of Medicine · R01 · FY2023 · CA

A high-throughput sample preparation platform for genomic and epigenetic analysis

$709,426
Greg Darlington · Matchstick Technologies, Inc. · R44 · FY2018 · GM

Inhibition of p53 Tumor Suppressor Function by HTLV-I

$709,332
John N. Brady · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Translational Application of Magnetic Hyperthermia Therapy with Adjuvant Therapies for Glioblastoma

$706,027
Constantinos George Hadjipanayis · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA

Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma

$705,826
Carol Thiele-Galetto · Basic Sciences · Z01 · FY2007 · CA

Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma

$705,167
Xiuli Wang · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA

Multi-Tensor Decompositions for Personalized Cancer Diagnostics and Prognostics

$704,509
Orly Alter · University Of Utah · U01 · FY2017 · CA

Genetic evolution of glioblastomas during radiation and temozolomide therapy

$704,210
Rameen Beroukhim · Dana-Farber Cancer Inst · R01 · FY2015 · CA

Brain Tumors - Immunological and Biological Studies

$703,967
Darell D Bigner · Duke University · R37 · FY2010 · CA

Organ-specific, Blood Protein Biomarkers for an Informative Diagnosis of Brain an

$703,861
Leroy E Hood · California Institute Of Technology · U54 · FY2012 · CA

Development and optimization of highly effective treatments in patients with head and neck cancer using in situ implantable microdevices

$703,540
Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2025 · CA

The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center

$703,315
William C Hahn · Dana-Farber Cancer Inst · U01 · FY2015 · CA

Efficacy of Dendritic Cell Vaccines Targeting CMV in Glioblastoma (phase 2 DC vaccine)

$703,160
Duane A. Mitchell · University Of Florida · R01 · FY2018 · CA

Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells

$703,154
Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2025 · CA

Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress

$702,000
Christopher D Willey · University Of Alabama At Birmingham · U01 · FY2022 · CA

Targeting platinum(IV) prodrug to GBM tumors using a brevican-binding peptide

$701,557
Choi-Fong Cho · Brigham And Women'S Hospital · R01 · FY2022 · CA

Metallofullerene Nanoplatform for Imaging & Treatment

$700,309
Panos Peter Fatouros · Virginia Commonwealth University · R01 · FY2007 · CA

Fast high-resolution simultaneous metabolic and multiparametric imaging of the whole brain

$700,067
Zhi-Pei Liang · University Of Illinois At Urbana-Champaign · U01 · FY2025 · EB

Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers

$700,051
Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA

Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers

$700,051
Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA

Integrative bioinformatics and functional characterization of oncogenic driver aberrations in cancer

$699,970
Gordon B. Mills · Oregon Health & Science University · U01 · FY2019 · CA

Discovering novel therapies for glioma patients

$699,386
Jing Wu · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma

$699,001
Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Role of Neurotrophins in the Development of the Mammalian Nervous System

$698,761
Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Signal Transduction by Tyrosine Phosphorylation

$698,480
Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2010 · CA